BridgeMD
New treatment option for Obesity
Official title Role of Adiposomes in Endothelial Dysfunction
ClinicalTrials.gov ID: NCT05199454
What this study is testing
- What it's testing
- The development of type II diabetes (T2D) is strongly associated with obesity and both are well-established risk factors for cardiovascular disease. Knowing that vascular dysfunction is an early event in the development of cardiovascular disease in obese diabetic (OB-T2D) patients, The investigators set their long-term goal to define molecular mechanisms of vascular dysfunction and corrective strategies that target these mechanisms such as physical activity and weight loss.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50
You may be able to join if
- BMI ≥ 35 kg/m2
- Between ages 18-50 years
- Not pregnant
- Diabetic (Current use of diabetes medication or fasting glucose ≥126 mg/dL)
- Medical clearance to participate in a moderate-intensity exercise program
You likely can't join if
- Pregnant women
- Current smokers
- Currently abusing alcohol or drugs
- Chronic heart, liver, or kidney diseases, autoimmune diseases, or cancer
- Non-English speakers
- History of allergic reactions to lidocaine
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.